CIK 0001401914 · Non-accelerated filer<br>Smaller reporting company
Dare Bioscience, Inc.
Sign in to watch- Ticker
- DARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 204139823
- Phone
- 858-926-7655
- Business address
- 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO, CA, 92122
- Former names
- Cerulean Pharma Inc., Tempo Pharmaceuticals Inc
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Results of operations
- 10-K Report Annual Report
- 4 Open-market buy Director bought 2,291 shares at an average $2.08 ($4,763)
- 4 Open-market buy Director bought 8,960 shares at an average $2.10 ($18,842)
- 4 Open-market buy Director bought 8,811 shares at an average $2.00 ($17,645)
- 4 Open-market buy Director bought 8,850 shares at an average $2.05 ($18,172)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 9,000 shares at an average $2.15 ($19,318)
- 4 Open-market buy Director bought 8,563 shares at an average $2.30 ($19,706)
- 4 Open-market buy Director bought 8,413 shares at an average $2.32 ($19,540)
- 4 Open-market buy Director bought 5,700 shares at an average $2.38 ($13,550)
- 4 Open-market buy Director bought 9,000 shares at an average $2.46 ($22,132)
- 4 Open-market buy Director bought 8,800 shares at an average $2.39 ($21,075)
- 4 Open-market buy Director bought 9,000 shares at an average $2.28 ($20,523)
Page 31 of 39 · 778 filings